Your browser doesn't support javascript.
loading
Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease.
Dittmar, David J; Pielmeier, Franziska; Strieder, Nicholas; Fischer, Alexander; Herbst, Michael; Stanewsky, Hanna; Wenzl, Niklas; Röseler, Eveline; Eder, Rüdiger; Gebhard, Claudia; Schwarzfischer-Pfeilschifter, Lucia; Albrecht, Christin; Herr, Wolfgang; Edinger, Matthias; Hoffmann, Petra; Rehli, Michael.
Afiliación
  • Dittmar DJ; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Pielmeier F; BioNTech SE, 82061, Neuried, Germany.
  • Strieder N; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Fischer A; Leibniz Institute for Immunotherapy, 93053, Regensburg, Germany.
  • Herbst M; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Stanewsky H; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Wenzl N; Institute of Experimental Immunology, Research Unit Tumorimmunology, University of Zurich, Zurich, Switzerland.
  • Röseler E; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Eder R; Leibniz Institute for Immunotherapy, 93053, Regensburg, Germany.
  • Gebhard C; Leibniz Institute for Immunotherapy, 93053, Regensburg, Germany.
  • Schwarzfischer-Pfeilschifter L; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Albrecht C; Leibniz Institute for Immunotherapy, 93053, Regensburg, Germany.
  • Herr W; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Edinger M; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Hoffmann P; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Rehli M; Department of Internal Medicine III, University Hospital Regensburg, 93053, Regensburg, Germany. matthias.edinger@ukr.de.
Nat Commun ; 15(1): 3224, 2024 Apr 15.
Article en En | MEDLINE | ID: mdl-38622133
ABSTRACT
The adoptive transfer of regulatory T cells is a promising strategy to prevent graft-versus-host disease after allogeneic bone marrow transplantation. Here, we use a major histocompatibility complex-mismatched mouse model to follow the fate of in vitro expanded donor regulatory T cells upon migration to target organs. Employing comprehensive gene expression and repertoire profiling, we show that they retain their suppressive function and plasticity after transfer. Upon entering non-lymphoid tissues, donor regulatory T cells acquire organ-specific gene expression profiles resembling tissue-resident cells and activate hallmark suppressive and cytotoxic pathways, most evidently in the colon, when co-transplanted with graft-versus-host disease-inducing conventional T cells. Dominant T cell receptor clonotypes overlap between organs and across recipients and their relative abundance correlates with protection efficacy. Thus, this study reveals donor regulatory T cell selection and adaptation mechanisms in target organs and highlights protective features of Treg to guide the development of improved graft-versus-host disease prevention strategies.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Enfermedad Injerto contra Huésped Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Enfermedad Injerto contra Huésped Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania